PT  - JOURNAL ARTICLE
AU  - Kurita, Junko
AU  - Sugawara, Tamie
AU  - Sugishita, Yoshiyuki
AU  - Ohkusa, Yasushi
TI  - Negative Excess Mortality in Pneumonia Death caused by COVID-19 in Japan
AID  - 10.1101/2021.01.22.21250283
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.22.21250283
4099  - http://medrxiv.org/content/early/2021/04/12/2021.01.22.21250283.short
4100  - http://medrxiv.org/content/early/2021/04/12/2021.01.22.21250283.full
AB  - Background Since the emergence of COVID-19, cases of excess mortality from all causes have been very few in Japan.Object To evaluate COVID-19 effects precisely, we specifically examine deaths caused by pneumonia and examine excess mortality attributable to pneumonia in Japan.Method We applied the NIID model to pneumonia deaths from 2005 up through November, 2020 for the whole of Japan. Introduction of routine pneumococcal vaccination for elderly people and revision in ICD10 were incorporated into the estimation model.Results No excess mortality was found for 2020. However, negative excess mortality was observed as 178 in May, 314 in June, and 75 in July. No negative excess mortality was not found between August and November.Discussion and Conclusion Significantly negative excess mortality might reflect precautions taken by people including wearing masks, washing hands with alcohol, and maintaining social distance. They reduced the infection risk not only of for COVID-19 but also of other infectious diseases causing pneumonia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All information used for this study has been published. There is therefore no ethical issue related to this study. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesMinistry of Health, Labour and Welfare